| |
| | NIH Guide: COOPERATIVE RESEARCH FOR THE DEVELOPMENT OF VACCINES, ADJUVANTS, THERAPEUTICS, IMMUNOTHERAPEUTICS, AND DIAGNOSTICS FOR BIODEFENSE |
 | | The involvement of diverse disciplines (e.g., biochemists, structural biologists, protein chemists, pharmacologists, immunologists, molecular biologists, engineers and clinicians) within academia and industry in early stage product development is needed to bring sufficient knowledge to bear on the development of well-designed candidates for Vaccines, Adjuvants, Therapeutics, Immunotherapeutics and Diagnostics. |
| | Research Goals and Objectives Applications should address research that will advance the development of a Vaccine, Adjuvant, Therapeutic, Immunotherapeutic or Diagnostic that is an NIAID priority biodefense product ( http://www.niaid.nih.gov/dmid/bioterrorism/high_priority.htm) or any other Vaccine, Adjuvant, Therapeutic, Immunotherapeutic or Diagnostic specific for an NIAID Category A, B or C pathogen ( http://www.niaid.nih.gov/dmid/bioterrorism/bandc_priority.htm). |
| | IMMUNOTHERAPEUTICS Applications to discover and/or improve immune-based therapeutics including both broad-spectrum (innate immunity) and pathogen-specific (antibodies) approaches are invited. |
| grants.nih.gov /grants/guide/rfa-files/RFA-AI-02-026.html (131 words) |
|
